Clinical Trial Update: Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants [Phase 3]

View source ↗

Summary

Phase 3 study assessing conversion to Roxadustat in ESRD-related anemia, including patients on stable ESAs or as initial anemia therapy; trial completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Associated with End Stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia Associated With End Stage Renal Disease (ESRD) | Phase 3 | Status: COMPLETED | Results posted: 2022-09-13